Trial Profile
Pharmacokinetics and Safety of 50 mg/kg IV Levetiracetam (Keppra) in Full Term and Preterm Neonates.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Seizures
- Focus Pharmacokinetics
- 17 Nov 2011 Actual patient number is 7 according to ClinicalTrials.gov.
- 17 Nov 2011 Actual end date (1 Jul 2011) added as reported by ClinicalTrials.gov.
- 17 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.